Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis

AIDS

Volumn 11, Issue 15, 1997, Pages 1839-1844

  Cartledge, Jonathan D ^a   Midgley, Jennifer ^a   Gazzard, Brian G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Candidosis; Cross resistance; Fluconazole; HIV; Itraconazole; Ketoconazole; Susceptibility testing

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ARTICLE; CANDIDA ALBICANS; CROSS RESISTANCE; DRUG RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THRUSH;

EID: 0030828120     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199715000-00008     Document Type: Article

References (17)

1. Bailey GG, Perry FM, Denning DW, Mandal BK: Fluconazole-resistant candidiasis in an HIV cohort. AIDS 1994, 8:787-792.
2. Boken DI, Swindells S, Rinaldi MG: Fluconazole resistant Candida albicans in HIV-infection. IX International Conference on AIDS/IV STD World Congress. Berlin, June 1993 [abstract PO-B08-1358].
3. Cartledge JD, Midgley J, Youle M, Gazzard BG: Itraconazole cyclodextrin solution: effective treatment for HIV-related candidosis unresponsive to other azole therapy. J Antimicrob Chemother 1994, 33:1071-1073.
4. Fox R, Neal KR, Leen CLS, Ellis MF, Mandal BK: Fluconazole-resistant Candida in AIDS [letter]. J Infect 1991, 22:201-202
5. Kitchen VS, Savage M, Harris JRW: Candida albicans resistance in AIDS [letter]. J Infect 1991, 22:204-205.
6. Smith D, Boag F, Midgley J, Gazzard B: Fluconazole-resistant Candida in AIDS [letter]. J Infect 1991, 23:345-346.
7. Odds FC: Antifungal susceptibility testing of Candida species by relative growth measurement at single concentrations of anti-fungal agents. Antimicrob Agents Chemother 1992, 36:1727-1737.
8. Cartledge JD, Midgley J, Gazzard BG: Relative growth measurement of Candida species in a single concentration of fluconazole predicts clinical response to fluconazole in patients with HIV-related oral candidosis. J Antimicrob Chemother 1996, 34:247-252.
9. Cartledge JD, Midgley J, Gazzard BG: Itraconazole cyclodextrin solution: the role of in vitro susceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole-susceptible oral candidosis. AIDS 1997, 11:163-168.
10. Cartledge JD, Midgley J, Gazzard BG: Clinical response to ketoconazole of HIV-related oral candidosis is predicted by Odds' relative growth method of susceptibility testing. J Antimicrob Chemother 1997, 40:117-119.
11. Warnock DW: Azole drug resistance in Candida species. J Med Microbiol 1992, 37:225-226.
12. Lake-Bakaar G, Winston T, Lake-Bakaar D, et al.: Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988, 109:471-473.
13. Vanden Bossche H, Marichal P, Gorrens J, Bellens D, Moereels H, Janssen PAJ: Mutation of cytochrome P450 dependent 14 alpha demethylase results in decreased affinity for azole anti-fungals. Biochem Soc Trans 1990, 18:56-59.
14. Vanden Bossche H, Marichal P, Odds FC, Le Jeune L, Coone MC: Characterisation of an azole resistant Candida glabrata isolate. Antimicrob Agents Chemother 1992, 36:2602-2610.
15. Sanglard D, Kuchler K, Ischer F, Pagani J-L, Monod M, Bille J: Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 1995, 39:2378-2386.
16. Clark FS, Parkinson T, Hitchcock CA, Gow NAR: Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance. Antimicrob Agents Chemother 1996, 40:419-425.
17. Hitchcock CA, Pye GW, Troke PF, Johnson EM, Warnock DW: Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother 1993, 37:1962-1965.